Progressive Supranuclear Palsy clinical trials at UCSD
5 in progress, 1 open to eligible people
ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration (ALLFTD)
open to eligible people ages 18 years and up
ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration (ALLFTD) represents the formalized integration of ARTFL (U54 NS092089; funded through 2019) and LEFFTDS (U01 AG045390; funded through 2019) as a single North American research consortium to study FTLD for 2019 and beyond.
San Diego, California and other locations
Progressive Supranuclear Palsy Clinical Trial Platform
Sorry, not yet accepting patients
The Progressive Supranuclear Palsy Clinical Trial Platform (PTP) is a multi-center, multi-regimen clinical trial evaluating the safety and efficacy of investigational products for the treatment of PSP.
Progressive Supranuclear Palsy Clinical Trial Platform - Regimen A: AADvac1
Sorry, not yet accepting patients
The Progressive Supranuclear Palsy Clinical Trial Platform (PTP) is a multi-center, multi-regimen clinical trial evaluating the safety and efficacy of investigational products for the treatment of PSP. Regimen A will evaluate the safety and efficacy of a single study drug, AADvac1, in participants with PSP.
Progressive Supranuclear Palsy Clinical Trial Platform - Regimen B: LM11A-31
Sorry, not yet accepting patients
The Progressive Supranuclear Palsy Clinical Trial Platform (PTP) is a multi-center, multi-regimen clinical trial evaluating the safety and efficacy of investigational products for the treatment of PSP. Regimen B will evaluate the safety and efficacy of a single study drug, LM11A-31, in participants with PSP.
Automated Imaging Differentiation of Parkinsonism
Sorry, in progress, not accepting new patients
The purpose of this study is to test the performance of the AID-P across 21 sites in the Parkinson Study Group. Each site will perform imaging, clinical scales, diagnosis, and will upload the data to the web-based software tool. The clinical diagnosis will be blinded to the diagnostic algorithm and the imaging diagnosis will be compared to the movement disorders trained neurologist diagnosis.
La Jolla, California and other locations
Our lead scientists for Progressive Supranuclear Palsy research studies include Gabriel Leger, MD Irene Litvan, MD.
Last updated: